Blyth (BTH +14.4%) trades higher after reporting Q4 revenue of $365M, well-ahead of the consensus estimate of analysts that called for $296.9M. The company says that sales of its ViSalus weight-loss products soared 627% Y/Y to $96.7M.
Blyth (BTH +14.4%) trades higher after reporting Q4 revenue of $365M, well-ahead of the...
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs